However, this may be important for future studies given the genetic evidence [8••] suggesting a robust genetic association in relation to antibody specificity when compared to clinical syndromes (PR3-ANCA disease is associated with HLA-DP, SERPINA1 and PRTN3, while MPO-ANCA disease is associated with HLA-DQ). Here, PRTN3 is linked to glycogen storage disease VI.